BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 23388370)

  • 21. Device-associated nosocomial infection rates in intensive care units at Cairo University hospitals: first step toward initiating surveillance programs in a resource-limited country.
    El-Kholy A; Saied T; Gaber M; Younan MA; Haleim MM; El-Sayed H; El-Karaksy H; Bazara'a H; Talaat M
    Am J Infect Control; 2012 Aug; 40(6):e216-20. PubMed ID: 22418610
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Surveillance for nosocomial and central line-related infections among pediatric hematology-oncology patients.
    Simon A; Fleischhack G; Hasan C; Bode U; Engelhart S; Kramer MH
    Infect Control Hosp Epidemiol; 2000 Sep; 21(9):592-6. PubMed ID: 11001263
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outbreak of catheter-associated Klebsiella oxytoca and Enterobacter cloacae bloodstream infections in an oncology chemotherapy center.
    Watson JT; Jones RC; Siston AM; Fernandez JR; Martin K; Beck E; Sokalski S; Jensen BJ; Arduino MJ; Srinivasan A; Gerber SI
    Arch Intern Med; 2005 Dec 12-26; 165(22):2639-43. PubMed ID: 16344422
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Central line-associated bloodstream infection rate elevation: Attributable to National Healthcare Safety Network surveillance definition changes, ongoing opportunities for infection prevention, or both?
    Corley A; Cantara M; Gardner J; Trexler P; Rock C; Maragakis LL
    Am J Infect Control; 2017 Sep; 45(9):1030-1032. PubMed ID: 28736032
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Device use ratio measured weekly can reliably estimate central line-days for central line-associated bloodstream infection rates.
    Shelly MA; Concannon C; Dumyati G
    Infect Control Hosp Epidemiol; 2011 Jul; 32(7):727-30. PubMed ID: 21666408
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attempts to change culture in a line-obsessed pediatric world: the Riley Heart Center line initiative.
    Cox E; Flaspohler T; Jennings A; Bringman S; Crumpacker B; Cordes T; Turrentine MW
    Am J Infect Control; 2011 Oct; 39(8):690-692. PubMed ID: 21664006
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Distribution of pathogens in central line-associated bloodstream infections among patients with and without neutropenia following chemotherapy: evidence for a proposed modification to the current surveillance definition.
    Steinberg JP; Robichaux C; Tejedor SC; Reyes MD; Jacob JT
    Infect Control Hosp Epidemiol; 2013 Feb; 34(2):171-5. PubMed ID: 23295563
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for bacteremia and central line-associated blood stream infections in children with acute myelogenous leukemia: A single-institution report.
    Rogers AE; Eisenman KM; Dolan SA; Belderson KM; Zauche JR; Tong S; Gralla J; Hilden JM; Wang M; Maloney KW; Dominguez SR
    Pediatr Blood Cancer; 2017 Mar; 64(3):. PubMed ID: 27616655
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Changing Epidemiology of Catheter-Related Bloodstream Infections in Cancer Patients.
    Chaftari AM; Hachem R; Jiang Y; Shah P; Hussain A; Hamal ZA; Yousif A; Jordan M; Michael M; Raad I
    Infect Control Hosp Epidemiol; 2018 Jun; 39(6):727-729. PubMed ID: 29770754
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Infections from CVC in the pediatric neoplastic patient. Single institution experience.
    Coco I; Casale F; Indolfi P
    Minerva Pediatr; 2012 Aug; 64(4):385-94. PubMed ID: 22728610
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact of revising the National Nosocomial Infection Surveillance System definition for catheter-related bloodstream infection in ICU: reproducibility of the National Healthcare Safety Network case definition in an Australian cohort of infection control professionals.
    Worth LJ; Brett J; Bull AL; McBryde ES; Russo PL; Richards MJ
    Am J Infect Control; 2009 Oct; 37(8):643-8. PubMed ID: 19589619
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ambulatory pediatric oncology CLABSIs: epidemiology and risk factors.
    Rinke ML; Milstone AM; Chen AR; Mirski K; Bundy DG; Colantuoni E; Pehar M; Herpst C; Miller MR
    Pediatr Blood Cancer; 2013 Nov; 60(11):1882-9. PubMed ID: 23881643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vital signs: central line-associated blood stream infections--United States, 2001, 2008, and 2009.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Mar; 60(8):243-8. PubMed ID: 21368740
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Laboratory-based surveillance of hospital-acquired catheter-related bloodstream infections in Catalonia. Results of the VINCat Program (2007-2010).
    Almirante B; Limón E; Freixas N; Gudiol F;
    Enferm Infecc Microbiol Clin; 2012 Jun; 30 Suppl 3():13-9. PubMed ID: 22776149
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Changing epidemiology of central venous catheter-related bloodstream infections: increasing prevalence of Gram-negative pathogens.
    Marcos M; Soriano A; Iñurrieta A; Martínez JA; Romero A; Cobos N; Hernández C; Almela M; Marco F; Mensa J
    J Antimicrob Chemother; 2011 Sep; 66(9):2119-25. PubMed ID: 21665905
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bloodstream and central line isolates from hematopoietic stem cell transplant recipients: data from a developing country.
    Ali N; Adil SN; Shaikh MU
    Transpl Infect Dis; 2014 Feb; 16(1):98-105. PubMed ID: 24383473
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bloodstream infections in pediatric oncology outpatients: a new healthcare systems challenge.
    Smith TL; Pullen GT; Crouse V; Rosenberg J; Jarvis WR
    Infect Control Hosp Epidemiol; 2002 May; 23(5):239-43. PubMed ID: 12026147
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Infectious complications associated with the use of central venous catheters in patients undergoing hematopoietic stem cell transplantation.
    Martinho GH; Romanelli RM; Teixeira GM; Macedo AV; Chaia JM; Nobre V
    Am J Infect Control; 2013 Jul; 41(7):642-4. PubMed ID: 23375574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hospital-wide reduction in central line-associated bloodstream infections: a tale of two small community hospitals.
    Gozu A; Clay C; Younus F
    Infect Control Hosp Epidemiol; 2011 Jun; 32(6):619-22. PubMed ID: 21558777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk for Health Care-Associated Bloodstream Infections in Pediatric Oncology Patients With Various Malignancies.
    Thurman CB; Abbott M; Liu J; Larson E
    J Pediatr Oncol Nurs; 2017; 34(3):196-202. PubMed ID: 28038498
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.